19
government through importing less expensive, but nonstandard hygiene
products, medical equipment, medical prostheses and medicines. This
comes at a time that there is still small room for cooperation between
foreign pharmaceutical companies and pharmaceuticals distributors with
Iranian companies. For example, in an interview in October 2016, Rasoul
Dinarvand, head of Food and Drug Administration of Iran, complained
about the measure taken by officials of CPhI exhibition to bar Iranian
companies from taking part at the event.
11